What is a Vasculasure Closure Device?
A Vascular Closure Device (VCD) is a medical tool designed to seal puncture wounds created after interventional procedures such as angioplasty, stenting, or diagnostic catheterization. VCDs are crucial in promoting patient comfort and facilitating early mobilization by reducing recovery time. They minimize the need for manual compression and associated risks, like bleeding and hematoma formation.
Vascular Closure Devices have evolved significantly over the years, offering various methods to achieve hemostasis, or stopping of blood flow. Broadly, they can be categorized into mechanical and biological closure systems. Understanding these categories and their distinct offerings is essential for healthcare professionals to choose the most suitable device for specific patient needs.
Mechanical Vascular Closure Devices
Mechanical VCDs use external compression to close the arterial wall puncture. They are simple to use and do not require complex preparation. The most common type is the Clip-based VCD, which uses a metallic clip to approximate and hold the arterial wall together.
Another type of mechanical VCD is the Suture-based device, which uses a non-absorbable or absorbable suture to approximate and stitch the puncture site. These devices aim to provide a stronger closure, reducing the risk of leakage and hematoma formation. However, they may require more technical skill for application.
Clip-based VCDs
Clip-based VCDs, such as the Perclose ProGlide, work by placing a small metallic clip across the artery to approximate the puncture site. The clip holds the tissue together, allowing the body's natural healing process to seal the wound. This type of device is generally quick and easy to use, promoting rapid patient recovery.
Clip-based VCDs are suitable for large-bore punctures, making them ideal for procedures involving large sheath sizes. They are particularly useful in obese patients, where manual compression may be challenging. However, they may not be as effective in small vessels or in patients with severeellentia, a disorder causing fragility of blood vessels.
Suture-based VCDs
Suture-based VCDs, like the ProStar XL, use a non-absorbable or absorbable suture to approximate and stitch the arterial wall together. This method provides a strong, secure closure, reducing the risk of leakage and hematoma formation. The device uses a specialized needle to deploy the suture, facilitating quick and easy application.
Suture-based VCDs are ideal for patients at high risk of bleeding, such as those with small vessel size, severeellentia, or those requiring large sheath sizes. They can also be used in patients where rapid mobilization is crucial, like postoperative or geriatric patients. However, their use may require more technical skill and have a slightly longer learning curve.
Biological VCDs
Biological VCDs use naturally occurring materials, such as collagen or autologous blood, to facilitate the body's natural healing process. They are typically easier to use and have a lower risk of complications compared to mechanical devices.
These devices promote hemostasis by providing a biological scaffold for the body's natural clotting cascade. They are ideal for patients at high risk of bleeding, with small vessel size, or severeellentia. However, they may not be as effective in large-bore punctures or in patients with impaired clotting mechanisms.
Collagen-based VCDs
Collagen-based VCDs, such as the Angio-Seal, use purified collagen, a naturally occurring protein, to facilitate hemostasis. The device deploys a collagen plug into the puncture site, which absorbs blood and promotes the formation of a stable clot.
Collagen-based VCDs are easy to use and provide a rapid and reliable closure. They are suitable for a wide range of patients and procedures, including those with higher bleeding risk. However, they may not be as effective in patients with impaired clotting mechanisms or those requiring large sheath sizes.
Autologous Blood-based VCDs
Autologous Blood-based VCDs, like the ExoSeal, use the patient's own blood to facilitate hemostasis. The device uses a specialized needle to withdraw a small amount of blood, which is then deployed at the puncture site. The blood enhances the clotting cascade, promoting a rapid and stable closure.
Autologous Blood-based VCDs are biocompatible and provide a natural means of closure. They are ideal for patients at high risk of bleeding, with impaired clotting mechanisms, or those requiring large sheath sizes. However, they may not be suitable for patients with bleeding disorders or those at risk of infection.
As the medical field continues to advance, so too do the options for Vascular Closure Devices. Each device offers unique advantages, catering to a wide range of patient needs and procedure types. The choice of device depends on the individual patient's demographics, risk factors, and the interventional procedure being performed. By keeping up-to-date with the latest developments, healthcare professionals can ensure they are using the most appropriate device for each patient, promoting the best possible outcome.